Speaker Profile
Ph.D., CSO, Nurix Tx
Biography
Gwenn M. Hansen, Ph.D., has served as Chief Scientific Officer of Nurix since June 2020, where she leads drug discovery and development from program inception to initial clinical proof of concept. Since joining Nurix in 2015, Dr. Hansen has focused on establishing the company's integrated DEL-AI discovery platform and forging academic and pharmaceutical partnerships to help build a sustainable pipeline of transformative therapeutics. Prior to joining Nurix, Dr. Hansen was an Associate Professor in the Center for Drug Discovery at Baylor College of Medicine and prior to that served in a variety of discovery-focused roles at Lexicon Pharmaceuticals. She completed postdoctoral training at M.D. Anderson Cancer Center and Baylor College of Medicine. Dr. Hansen holds a B.A. in Biology and Psychology from Gustavus Adolphus College and a Ph.D. in Biomedical Sciences from the University of Tennessee, Knoxville.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Catriona Jamieson, UC San Diego
PMWC Award Ceremony
• Emmanuelle Charpentier, Max Planck (J. Craig Venter Visionary Award · Nobel Laureate)
• Jay Bradner, Amgen (Pioneer)
• Adrian Krainer, Cold Spring Harbor Laboratory (Luminary)
• Randy Schekman, UC Berkeley (Nobel Laureate, Pioneer)
Featured Speakers
• Emmanuelle Charpentier, Max Planck
• Randy Schekman, UC Berkeley
• Jay Bradner, Amgen
• Adrian Krainer, Cold Spring Harbor Laboratory
• Alexis C. Komor, UC San Diego
• Nicole Gaudelli, GV
• Rachel Haurwitz, Caribou Bio
• Gene Yeo, UC San Diego
• Timothy Yu, Boston Children's / Harvard
• Shicheng Guo, Arrowhead Pharmaceuticals
• Mark A. Kay, Stanford
• Niren Murthy, UC Berkeley
• Ben Deverman, Broad Institute
• Stanley Crooke, n-Lorem / Ionis
Programming Protein Fate
Molecular glues, degraders, and induced proximity crossing into medicines.
Genome Editing Beyond the First Wave
Base, prime, and CRISPR-enabled editing moving from correction to clinic.
RNA Editing, Splice Modulation & Programmable RNA
RNA editing, ASOs, and splice modulation with chemistry already reaching patients.
In Vivo Delivery & Vector Engineering
AAV, LNP, and next-generation vectors that decide what is treatable.
From N-of-1 to Platform
Evidence, CMC, regulation, and access for individualized genetic medicines.
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
